Bausch plus Lomb News - BLCO

Company Name	Stock Ticker Symbol	Market	Type
Bausch plus Lomb Corporation	BLCO	NYSE	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	14.90	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
				14.90

more quote information »

Recent News

Date	Time	Source	Heading
4/18/2024	07:00	BW	Bausch + Lomb Reports More Than 84 Million Units of Contact..
4/15/2024	12:00	BW	Bausch + Lomb Will Release First-Quarter 2024 Financial..
3/27/2024	07:00	BW	Bausch + Lomb Will Present New Scientific Data and Analyses..
3/04/2024	17:57	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/04/2024	17:54	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/04/2024	17:52	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/01/2024	16:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/01/2024	16:43	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/01/2024	16:41	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/01/2024	16:35	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/28/2024	08:12	EDGAR2	Form 8-K - Current report
2/28/2024	08:00	BW	Bausch + Lomb Announces Appointment of Karen L. Ling to..
2/21/2024	07:00	EDGAR2	Form 8-K - Current report
2/21/2024	07:00	GLOBE	Emergent BioSolutions Appoints Industry Leader Joseph C...
2/21/2024	06:58	BW	Bausch + Lomb Announces Fourth-Quarter and Full-Year 2023..
2/05/2024	12:00	BW	Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2023..
1/08/2024	06:59	BW	Bausch + Lomb Receives FDA Approval for TENEO™ Excimer Laser..
1/03/2024	16:39	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/03/2024	09:00	BW	Bausch + Lomb to Participate in the 42nd Annual J.P. Morgan..
11/15/2023	06:59	BW	Bausch + Lomb Reports More Than 76 Million Units of Contact..
11/13/2023	16:47	EDGAR2	Form 8-K/A - Current report: [Amend]
11/07/2023	17:00	EDGAR2	Form 8-K/A - Current report: [Amend]
11/01/2023	17:03	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/01/2023	07:02	EDGAR2	Form 8-K - Current report
11/01/2023	06:58	BW	Bausch + Lomb Announces Third-Quarter 2023 Results and..
10/26/2023	06:59	BW	Bausch + Lomb Will Present New Scientific Data and Analyses..
10/16/2023	12:00	BW	Bausch + Lomb Will Release Third-Quarter 2023 Financial..
10/04/2023	06:59	BW	Bausch + Lomb Will Present New Scientific Data and Analyses..
10/03/2023	17:14	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/29/2023	16:24	EDGAR2	Form 8-K - Current report
9/29/2023	10:00	BW	Bausch + Lomb Completes Acquisition of XIIDRA®
9/26/2023	06:59	BW	Bausch + Lomb Launches LUMIFY EYE ILLUMINATIONS™ in the..
9/20/2023	06:59	BW	Bausch + Lomb’s ONE by ONE and Biotrue® Eye Care Recycling..
9/14/2023	17:26	EDGAR2	Form 8-K - Current report
9/14/2023	17:25	BW	Bausch + Lomb Announces Pricing of Senior Secured Notes..
9/12/2023	06:59	BW	Bausch + Lomb Launches MIEBO™ (Perfluorohexyloctane..
9/11/2023	07:22	EDGAR2	Form 8-K - Current report
9/11/2023	07:07	BW	Bausch + Lomb Announces Launch of Proposed Financing for..
9/06/2023	17:58	BW	Bausch + Lomb Announces Disclosure of Historical and Pro..
9/06/2023	17:28	EDGAR2	Form 8-K - Current report
9/06/2023	06:59	BW	Bausch + Lomb Will Present New Scientific Data on its..
8/29/2023	17:05	EDGAR2	Form 8-K/A - Current report: [Amend]
8/29/2023	07:00	BW	Bausch + Lomb Will Participate at the 2023 Wells Fargo..
8/24/2023	07:00	BW	Bausch + Lomb Announces Expiration of Hart-Scott-Rodino..
8/02/2023	17:14	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
8/02/2023	17:09	EDGAR2	Form S-3ASR - Automatic shelf registration statement of..
8/02/2023	16:18	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/02/2023	07:02	EDGAR2	Form 8-K - Current report
8/02/2023	06:59	BW	Bausch + Lomb Announces Second-Quarter 2023 Results and..
8/01/2023	08:00	BW	Bausch + Lomb Solidifies Leadership Team